Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Police probe side offers of COVID vaccines to Italian regions

Fri, 19th Feb 2021 17:39

By Emilio Parodi and Silvia Aloisi

MILAN, Italy, Feb 19 (Reuters) - Italian police are
investigating the offer of COVID-19 vaccines by unnamed
intermediaries to Veneto regional authorities, indicating a
possible attempt to create a black market parallel to the
national and EU level procurement process, two sources with
knowledge of the matter said on Friday.

Veneto governor Luca Zaia and regional health director
Luciano Flor said this week they were evaluating two offers they
received for a total of 27 million doses of the Pfizer
vaccine, without naming who had approached them.

Flor has said that the two offers were shortlisted from a
total of around 20 proposals the Veneto region had received from
various intermediaries in recent days, including some involving
AstraZeneca's vaccine and Russia's Sputnik one.

The approaches are unusual because the drugmakers that
manufacture the vaccines have struck deals with national
governments and, in the case of the European Union, with the EU
Commission, which has negotiated a procurement programme on
behalf of its members.

The Italian investigation is trying to establish whether a
parallel market had emerged, a source with direct knowledge of
the probe said. The source said it was not clear whether
drugmakers could legally sell their vaccines to non-governmental
entities in Europe.

"The regulatory framework is not clear at all," the source
told Reuters, speaking on condition of anonymity because the
probe is confidential and ongoing.

Andrew Widger, a spokesman for Pfizer, which has produced
its vaccine with German partner BioNTech, said
"currently, we are prioritising our available doses for supply
through established agreements with governments and
supra-government organisations".

"In the European Union, doses are supplied directly to
governments under the terms of the supply agreement with the
European Commission. No Pfizer/BioNTech vaccine is available
through intermediaries at this time," he added.

BioNTech did not immediately respond to a request for
comment.

A spokesman for AstraZeneca said the British-Swedish
drugmaker has not authorised any shipments of its vaccine
outside of its existing supply deal with the European Union.
There should not be any private-sector supply of the shots for
sale or distribution in Europe, he said.

The Russian Direct Investment Fund, Russia's sovereign
wealth fund which is responsible for marketing the Sputnik V
vaccine abroad, did not immediately reply to a request for
comment.

'DISTILLED WATER'

The EU Commission's head, Ursula von der Leyen, said this
week there were increasing cases of fraud and fraud attempts
related to coronavirus vaccines. She said the Commission was
taking action to bring those responsible to justice, adding it
could be extremely risky to take vaccines offered by black
market traders.

Zaia said on Friday he had asked his regional health
director Flor to write to Italy's NAS police, who specialise in
food and drugs fraud investigations, to inform them about the
vaccine offers.

Police visited the headquarters of the Veneto region on
Friday and took documents concerning the case, one of the
sources said.

"I welcome this operation (by the police) because it will
finally bring clarity and it will allow us to understand whether
we are dealing with fraudsters or not," Zaia told reporters.

Veneto has also contacted the national medicine agency AIFA
and Italy's special COVID-19 commissioner, Domenico Arcuri, to
ask them to evaluate whether the offers were legitimate.

"We have not conducted any negotiations on prices or
anything else as we are waiting to see if we can go ahead," Zaia
said. "We don't know if the vaccines are good or bad, if it's
just distilled water. We only did what we were bound to do - we
didn't go to the black market."

A spokesman for Arcuri confirmed the contacts with the
Veneto authorities, while AIFA had no comment.

In a related case, prosecutors in the central region of
Umbria are investigating a man who they say claimed to be a
legitimate trader and tried to sell doses of AstraZeneca
vaccines to regional authorities there.
(Additional reporting by Riccardo Bastianello in Padua, Ludwig
Burger in Frankfurt and Mike Erman in New York
Editing by Frances Kerry)

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.